D-0219-2018 Class III Terminated
FDA drug recall D-0219-2018 was initiated by Shionogi Inc. on May 24, 2017 and is designated Class III. Reason for recall: Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules The recall status is terminated (terminated Feb 28, 2018). Affected quantity: 968 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 24, 2018
- Initiation Date
- May 24, 2017
- Termination Date
- Feb 28, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 968 bottles
Product description
Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30
Reason for recall
Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules
Distribution pattern
U.S.A. Nationwide
Code information
Lot#: 7H66200103G, Exp 12/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0219-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026